This Guidance Note is intended to be an introduction into the Base Erosion and Profit Shifting (“BEPS”), particularly, into how the OECD BEPS initiatives are most likely to impact Life Science companies in the UK.

Rather than providing an overview of all 15 actions, this Note focusses on Actions 7, 8-10 and 13 . . .

This content is restricted to subscribers. To view this content please register an account.

Register now

If you are already a subscriber, please login below.